Skip to content
DataLookout
Menu

MindOCNCT04914923

Mindfulness-Based Interventions for OCD

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

Version history last read from ClinicalTrials.gov on Aug 31, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
    • Final enrollment: 297 participants (planned 420)
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Sep 2025 to Mar 2026
    • Site details revised at 2 of 2 sites
    v5
  3. Minor Collaborators: 3 to 2v4
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2021 to Nov 9, 2021
    • Site details revised at 2 of 2 sites
    v3
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change from baseline in OCD symptom severity, as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)
Timeframe: Baseline to 12 weeks

Secondary (8)

Change from baseline in OCD symptomatology, as measured by the OCI-R (Obsessive Compulsive Inventory - Revised).
Change from baseline in the experience of depression, anxiety and stress symptoms, as measured by the DASS-21 (Depression, Anxiety and Stress Scale - 21 items).
Change from baseline in various attitudes and beliefs related to obsessional thoughts, as measured by the OBQ-44 (Obsessional Beliefs Questionnaire - 44 items).
Change from baseline in aspects of mindfulness, as measured by the FFMQ (Five Facet Mindfulness Questionnaire).
Change from baseline in functional health and well-being, as measured by the SF-36 Health Survey (Short Form 36 item Health Survey).
Show 3 moreShow less
Change from baseline in the degree which individuals find distress intolerable, as measured by the DTS (Distress Tolerance Scale).
Change from baseline in the fear of consequences of anxiety, as measured by the ASI-3 (Anxiety Sensitivity Index).
Change from baseline in the time spent ruminating, as measured by the RRS (Ruminative Response Scale).

Arms and interventions

Cognitive Behaviour TherapyExperimental

This study arm will receive 12 weeks of cognitive behaviour therapy as an intervention.

Mindfulness-based Cognitive TherapyExperimental

This study arm will receive 12 weeks of a mindfulness-based cognitive therapy intervention, along with open mindfulness sessions via an EEG headset.

WaitlistNo intervention

This study arm will not receive an intervention for 12 weeks.

Devices: Muse

Behavioral: Cognitive Behaviour Therapy (CBT), Mindfulness-Based Cognitive Therapy (MBCT)

Sites

2 sites in 1 country